fda restrictions on bpc-157 compounding may take an important step toward opening the peptide floodgates this week 3 FOR 3. An FDA

3 FOR 3. An FDA advisory committee has now voted 86, with one abstention, to recommend BPC 157, KPV and TB 500 for inclusion on the 503A Bulks List. This is not FDA approval The experts will take votes on whether the FDA should allow seven popular peptides to be added to a list of substances that are safe for compounding by pharmacies. Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest What to Know About Peptides the FDA Is Considering for Use The New York Times

SKU: 77639743751 · From creatorsinfotech.com